EUVIMEDEUVIMED entdecken
Crossref

Inhibition of Cholesterol Transport from Lysosomes by Itraconazole Repolarizes Tumor-associated Macrophages to Anti-tumor M1 type

Yumi Takimoto, Hiroshi Tsubamoto, Yushi Tsubamoto, Atsushi Tamura, Roze Taniguchi, Kazuko Sakata, Tomoko Ueda, Sachiyo Narita, Y U Wakimoto, Seiji Mabuchi

Anticancer Research · 2025

DOI: 10.21873/anticanres.17866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yumi Takimoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan. Hauptthemen laut MEDLINE: Cholesterol, Tumor-Associated Macrophages, Lysosomes, Itraconazole.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Targeting tumor-associated macrophages (TAMs) represents a promising strategy for next-generation immunotherapy. This study investigates the underlying mechanisms of TAM repolarization from the pro-tumorigenic M2 phenotype to the anti-tumorigenic M1 phenotype induced by itraconazole (ITZ). MATERIALS AND METHODS: M2 macrophages derived from THP-1 cells were used in all experiments, and ITZ was administered at a concentration of 10-5 M. Morphological changes were monitored via time-lapse imaging. Single-cell RNA sequencing (scRNA-seq) and triple-color immunostaining for organelles, cholesterol, and the M1 marker interleukin (IL)-1β were performed with and without ITZ treatment. For inhibition studies, β-cyclodextrin polyrotaxane (βCD-PRX), a compound that removes cholesterol from lysosomes, was used. The effects were assessed by time-lapse imaging and western blot analysis of the M2 marker CD163. RESULTS: Following ITZ treatment, a subpopulation of M2 macrophages exhibited morphological changes, shedding dendrites and migrating, indicative of an M1-like phenotype. Additionally, intracellular lipid droplets enlarged and swelled. scRNA-seq analysis revealed that M2 macrophages with reduced lysosomal vesicle biogenesis transitioned to an M1-like phenotype and identified 1,142 significantly enriched pathways, including M1-related signaling activation and cholesterol metabolism and transport pathways. Immunofluorescence analysis confirmed that macrophages shifting toward an M1-like phenotype expressed IL-1β, with enlarged intracellular lipid droplets identified as cholesterol-containing lysosomes. Notably, M2 macrophages that had adopted an M1-like morphology in response to ITZ reverted to their original M2-like shape and exhibited increased CD163 expression following βCD-PRX treatment. CONCLUSION: Inhibition of lysosomal cholesterol release by ITZ reprogrammed M2 macrophages into an M1-like phenotype, revealing a novel mechanism that may serve as a foundation for developing innovative TAM-targeted immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolTumor-Associated MacrophagesLysosomesItraconazoleHumansBiological TransportTHP-1 CellsInterleukin-1beta

Stichwörter der Autor:innen

Tumor-associated macrophagecholesterolitraconazolelysosomerepolarization

Substanzen

CholesterolItraconazoleInterleukin-1beta

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Obstetrics and Gynecology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan; tsuba@hyo-med.ac.jp.
  • Department of Neuroscience and Cell Biology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Department of Organic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan.

Zitieren

APA

Takimoto, Y., Tsubamoto, H., Tsubamoto, Y., Tamura, A., Taniguchi, R., Sakata, K., Ueda, T., Narita, S., Wakimoto, Y. U., & Mabuchi, S. (2025). Inhibition of Cholesterol Transport from Lysosomes by Itraconazole Repolarizes Tumor-associated Macrophages to Anti-tumor M1 type. Anticancer Research. https://doi.org/10.21873/anticanres.17866

Vancouver

Takimoto Y, Tsubamoto H, Tsubamoto Y, Tamura A, Taniguchi R, Sakata K, et al. Inhibition of Cholesterol Transport from Lysosomes by Itraconazole Repolarizes Tumor-associated Macrophages to Anti-tumor M1 type. Anticancer Research. 2025. doi:10.21873/anticanres.17866

BibTeX
@article{Takimoto2025,
  author = {Takimoto, Yumi and Tsubamoto, Hiroshi and Tsubamoto, Yushi and Tamura, Atsushi and Taniguchi, Roze and Sakata, Kazuko and Ueda, Tomoko and Narita, Sachiyo and Wakimoto, Y U and Mabuchi, Seiji},
  title = {Inhibition of Cholesterol Transport from Lysosomes by Itraconazole Repolarizes Tumor-associated Macrophages to Anti-tumor M1 type},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17866}
}
Kostenlos starten →